Skip to content

Relationship between calcium supplements and cardiovascular disease

Acute effect of calcium supplementation on arterial stiffness and endothelial function in healthy volunteers aged 50 years and over

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000232831
Enrollment
25
Registered
2012-02-23
Start date
2011-05-17
Completion date
2012-04-23
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Calcium supplements increase bone density and are frequently prescribed to patients with osteoporosis. However, it is not certain whether they reduce the risk of fracture. A recent study from Auckland, New Zealand raised the possibility that calcium supplements might increase the risk of a heart attack (1). Therefore the medical community is reassessing the pros and cons of taking calcium supplements. After taking calcium tablets, the concentration of calcium in blood increases slightly for a few hours. The flow of calcium from blood into the muscle cells that line blood vessels causes them to contract. We hypothesize that the increase in blood calcium after taking calcium tablets makes the blood vessels contract and become stiffer, putting pressure on the heart. This study will assess the stiffness of blood vessels in 20 subjects before and after a single dose of calcium. We hope to determine whether arterial stiffening is a mechanism that could explain a relationship between calcium supplements and an increased risk of heart disease. Reference 1. Bolland MJ, Barber PA, Doughty RN et al. BMJ 2008; 336:262-266

Interventions

Subjects will be studied immediately before (i.e on the same day) and 3 hours after 1000 mg calcium citrate orally (one dose)

Sponsors

Dr Morton Burt
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
50 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

Age > 50 years

Exclusion criteria

Taking calcium or vitamin D (>300 IU/day) in the last 3 months Taking proton pump inhibitors in last 3 months Taking calcium channel blockers in the last 3 months Primary hyperparathyroidism Diabetes mellitus Atrial fibrillation Raynaud’s phenomenon

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026